u/nervgenerator

NervGen Announces Pricing of US$60.0 Million Public Offering of Securities

https://nervgen.com/nervgen-announces-pricing-of-us60-0-million-public-offering-of-securities/

u/nervgenerator — 8 hours ago

NervGen Announces Proposed Public Offering of Securities

https://nervgen.com/nervgen-announces-proposed-public-offering-of-securities/

u/nervgenerator — 1 day ago

▲ 52 r/NGENF+1 crossposts

NervGen Prepares RESTORE Phase 3 Trial in Chronic Tetraplegia With NVG-291

https://www.clinicaltrialvanguard.com/news/nervgen-prepares-restore-phase-3-trial-in-chronic-tetraplegia-with-nvg-291/

clinicaltrialvanguard.com

u/Heavy_Snow2152 — 2 days ago

NervGen Reports First Quarter 2026 Financial Results and Provides Business Updates

https://nervgen.com/nervgen-reports-first-quarter-2026-financial-results-and-provides-business-updates/

u/nervgenerator — 4 days ago

Specific milestones include the NVG-291 study, co-financed by Wings for Life with €2.56 million, which showed a 3.7-fold improvement in hand function for chronic SCI patients.

https://endurance.biz/2026/industry-news/wings-for-life-world-run-2026-raises-record-e9-2-million/

u/nervgenerator — 5 days ago

NervGen Pharma Narrows Quarterly Loss but Cash Reserves Decline in Q1 2026 Filing

https://www.tipranks.com/news/company-announcements/nervgen-pharma-narrows-quarterly-loss-but-cash-reserves-decline-in-q1-2026-filing

u/nervgenerator — 7 days ago

The upcoming earnings date for NervGen Pharma Corp. is May ...?

u/nervgenerator — 11 days ago

Life Sciences BC’s Post

https://www.linkedin.com/posts/lifesciences-bc_lsbcmember-activity-7449879461203722240-VnZO

u/nervgenerator — 17 days ago